Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pfizer, Inc.
FDA Inspection
•Pfizer, Inc.•December 13, 2024

Pfizer, Inc. – FDA Inspection, Dec 13, 2024

Record Details

This FDA Inspection record concerns Pfizer, Inc., with an inspection on December 13, 2024, issued by the New England District Office, covering human drugs.

Company
Pfizer, Inc.
Inspection Date
December 13, 2024
Product Type
Human Drugs
Office
New England District Office
Person
  • Matthew C. Watson (Issuing Officer)
View Company Profile

ID · d45be9cf-ef2e-4d2d-9638-08e91b31a22c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1256477
FDA center
Human Drugs
Project area
Bioresearch Monitoring: Human Drugs
Outcome
Form 483 issued

FDA Citations

2
  1. 21 CFR 58.130(a)Conduct: in accordance with protocol
  2. 21 CFR 58.33(f)Study director: transfer of data to archives

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pfizer, Inc.

25
DateClassificationOfficeProject area
October 24, 2025Not classifiedNew England District Office
August 30, 2024Not classifiedNew England District Office
July 19, 2024Not classifiedNew England District Office
April 19, 2023NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
October 28, 2022NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 25 other inspections on the company page
Other documents for Pfizer, Inc.
  • FDA Inspection 1284680 - 2025-10-24
  • FDA Inspection 1249289 - 2024-08-30
  • FDA Inspection 1230476 - 2024-07-19
  • FDA Inspection 1204434 - 2023-04-19
  • FDA Inspection 1190580 - 2022-10-28

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pfizer, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.